Ad­comm unan­i­mous­ly rec­om­mends En­ta­sis' bac­te­r­i­al pneu­mo­nia can­di­date for re­sis­tant in­fec­tions

All 12 mem­bers of the FDA’s An­timi­cro­bial Drugs Ad­vi­so­ry Com­mit­tee unan­i­mous­ly vot­ed Mon­day af­ter­noon in fa­vor of an an­tibi­ot­ic can­di­date from En­ta­sis Ther­a­peu­tics, say­ing that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER